Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
Clinical trial NCT01107626 · COMPLETED
Trial details
- NCT number
- NCT01107626
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-25
- Primary completion
- 2019-01-31
- Enrollment
- 1516
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.